Logo

Gene Logic to Help FDA Develop QC Standards for Genomic Data

Sep 14, 2007
NEW YORK (GenomeWeb News) - Gene Logic said today that it will work with the US Food and Drug Administration to develop quality control metrics that will help the agency assess the quality of genomic data submissions.
 
The collaboration is part of FDA's Critical Path Initiative. Gene Logic said that the collaboration's results will be released publicly as "an early step towards formulating industry-wide standards" for assessing genomic data. The company said that there are currently no such standards in place.
 
Donna Mendrick, vice president of toxicogenomics at Gene Logic, said in a statement that the project is “a step on the path to achieving a common understanding of key microarray QC procedures that may lead to the development of preliminary microarray data standards for the submission of microarray data to the FDA."

Breaking News
The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.